BCAX
Bicara Therapeutics
BCAX
BCAX
140 hedge funds and large institutions have $1.01B invested in Bicara Therapeutics in 2025 Q4 according to their latest regulatory filings, with 45 funds opening new positions, 45 increasing their positions, 35 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
14.52% more ownership
Funds ownership: 92% → 106.52% (+15%)
22% less funds holding in top 10
Funds holding in top 10: 9 → 7 (-2)
100% less call options, than puts
Call options by funds: $7K | Put options by funds: $3.29M
Holders
140
Holding in Top 10
7
Calls
$7K
Puts
$3.29M
Top Buyers
| 1 | +$47.3M | |
| 2 | +$45.2M | |
| 3 | +$27.7M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$18.1M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$13.2M |
Top Sellers
| 1 | -$26M | |
| 2 | -$19.3M | |
| 3 | -$9.91M | |
| 4 |
SSA
Schonfeld Strategic Advisors
New York
|
-$7.96M |
| 5 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$4.21M |
